Related Experiment Video
Updated: Aug 7, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Purinoceptors in microglia and neuropathic pain
Tuan Trang1, Simon Beggs, Michael W Salter
1University of Toronto Centre for the Study of Pain, Programmes in Brain and Behaviour and Cell Biology, Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada.
Abstract:
Emerging evidence indicates that microglia play a critical role in the pathogenesis of neuropathic pain, a debilitating chronic pain condition that can occur after peripheral nerve damage caused by disease, infection, or physical injury. Microglia are immunocompetent cells of the central nervous system and express various ionotropic P2X and metabotropic P2Y purinoceptors. After injury to a peripheral nerve, microglia in the spinal cord become activated and upregulate expression of the P2X4 receptor. Recent findings suggest that activation of P2X4 receptors evokes release of brain-derived neurotrophic factor from microglia and that this mediates microglia-neuron signaling leading to pain hypersensitivity. Thus, P2X4 receptors and the intracellular signaling mediators in microglia are promising therapeutic targets for the development of novel pharmacological agents in the management of neuropathic pain.
Insights
Microglia and their P2X4 receptors are key players in neuropathic pain development after nerve injury. Targeting these receptors offers a promising strategy for new pain management therapies.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglia, the central nervous system's immune cells, are increasingly implicated in neuropathic pain.
- Neuropathic pain arises from nerve damage and is often chronic and debilitating.
- Microglia express purinoceptors, including P2X4 receptors, which are relevant to pain signaling.
Purpose of the Study:
- To investigate the role of microglia and P2X4 receptors in neuropathic pain pathogenesis.
- To explore the signaling pathways involving P2X4 receptor activation in microglia.
- To identify potential therapeutic targets for neuropathic pain management.
Main Methods:
- Analysis of microglial activation in the spinal cord following peripheral nerve injury.
- Assessment of P2X4 receptor expression and function in activated microglia.
- Investigation of brain-derived neurotrophic factor release and its role in microglia-neuron signaling.
Main Results:
- Peripheral nerve injury leads to microglial activation and P2X4 receptor upregulation in the spinal cord.
- P2X4 receptor activation in microglia triggers brain-derived neurotrophic factor release.
- This signaling pathway contributes to the development of pain hypersensitivity.
Conclusions:
- Microglia-mediated P2X4 receptor signaling is a critical mechanism in neuropathic pain.
- P2X4 receptors and associated intracellular mediators in microglia represent viable therapeutic targets.
- Developing drugs targeting these pathways could lead to novel treatments for neuropathic pain.
Related Concept Videos
Nociception
Pain
Analgesia and Pain Management
Sensory Functions of the Skin
There are two main categories of receptors on the skin: capsulated and non-capsulated. The non-capsulated ones are mainly the pain receptors. The capsulated ones can be further categorized based on the...
Thermosensation
